FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078659 [Registered on: 27/12/2024] Trial Registered Prospectively
Last Modified On: 26/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Role Of Vishaghna Mahakashaya Ghnatvati And Vishaghna Lepa in Melasma 
Scientific Title of Study   A Study To Evaluate The Role Of Vishaghna Mahakashaya Ghanvati And Visaghna Lepa In Management Of Mukhshyavta W.S.R. To Melasma 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Praveen Kumar Tiwari 
Designation  PG Scholar 
Affiliation  Pt. Khushilal sharma govt ayurveda college, Bhopal 
Address  room no 228 Dept of Agad tantra evum vidhi vaidhyak pt khushilal sharma govt ayurveda college bhopal Bhopal MADHYA PRADESH

Bhopal
MADHYA PRADESH
462007
India 
Phone  8770962368  
Fax    
Email  praveentiwari2804@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Praveen Kumar Tiwari 
Designation  PG Scholar 
Affiliation  Pt. Khushilal sharma govt ayurveda college, Bhopal 
Address  room no 228 Dept of Agad tantra evum vidhi vaidhyak pt khushilal sharma govt ayurveda college bhopal Bhopal MADHYA PRADESH


MADHYA PRADESH
462007
India 
Phone  8770962368  
Fax    
Email  praveentiwari2804@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Praveen Kumar Tiwari 
Designation  PG Scholar 
Affiliation  Pt. Khushilal sharma govt ayurveda college, Bhopal 
Address  room no 228 Dept of Agad tantra evum vidhi vaidhyak pt khushilal sharma govt ayurveda college bhopal Bhopal MADHYA PRADESH


MADHYA PRADESH
462007
India 
Phone  8770962368  
Fax    
Email  praveentiwari2804@gmail.com  
 
Source of Monetary or Material Support  
Pt. Khushilal sharma govt ayurveda college Bhopal 462003 m p india  
 
Primary Sponsor  
Name  Pt Khushilal sharma govt ayurveda college Bhopal 
Address  Nehru nagar kolar bypass behind MANIT Science hills Bhopal 462003 MP india 
Type of Sponsor  Other [ayurved medical collage and hospital] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
praveen tiwari  pt khushilal sharma govt hospital  pt khushilal sharma govt college an hospital nehru nagar kolar bypass near MANIT Bhopal MADHYA PRADESH
Bhopal
MADHYA PRADESH 
8770962368

praveentiwari2804@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L811||Chloasma. Ayurveda Condition: VYANGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: vishaghna mahakashya ghan vati, Reference: charak samhita, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -sukhoshna jala), Additional Information: -
2Comparator Arm (Non Ayurveda)-placebocapsule filled with roasted semolina of 500 mg twice a day
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  patients having cardinal sign and symptoms of mukhshyavta (melasma)as in ayurvedic classics and contemporary science
diagnosed mild and moderate cases of melasma 
 
ExclusionCriteria 
Details  patients having disease like urticaria with angioedema diabetes mellitus tuberculosis severe cardiac disease carcinoma
patients having major systemic illness
pregnant and lactating mothers will be excluded
patient without written consent form  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
it is expected that at the end of study we would be able tp demonstrate the efficacy of vishaghna mahakashaya ghanvati and vishaghna lepa in the management of mukhshyavta  12 months 
 
Secondary Outcome  
Outcome  TimePoints 
It is further expected that this study will be able
to provide information related to the safety of the
drug in the management of mukhshyavta 
12 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   from this study,it is expected that we will be able to demonstrate the therapeutic effect of visaghna mahakashaya ghanvati along with  external application of vishaghna lepa in mukhashyavata (melasma)
 
Close